This is a line-in-the-sand moment for legal cannabis. In this episode of Higher Exchanges, Jesse Redmond and Morgan Paxhia break down the Schedule III announcement alongside policy expert Hirsh Jain and capital markets veteran Scott Grossman. We unpack what just happened, why it matters, and what could come next for cannabis policy and markets. We cover: • A clear overview of the Schedule III news and first reactions • What changes on the policy side — including CBD and Medicare...
All content for Higher Exchanges is the property of Higher Exchanges and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
This is a line-in-the-sand moment for legal cannabis. In this episode of Higher Exchanges, Jesse Redmond and Morgan Paxhia break down the Schedule III announcement alongside policy expert Hirsh Jain and capital markets veteran Scott Grossman. We unpack what just happened, why it matters, and what could come next for cannabis policy and markets. We cover: • A clear overview of the Schedule III news and first reactions • What changes on the policy side — including CBD and Medicare...
This week on Higher Exchanges, we dive into the chaos and clarity surrounding cannabis reform, capital markets, and hemp regulation. Joining us is Scott Grossman of Turning Point Brands for a timely roundtable on what’s real, what’s noise, and what could actually move the needle. 🔍 Topics include: Schedule 3 speculation: Who’s driving the renewed chatter, and what do Appropriations moves, VA access, and the DEA vote on Terrance Cole really mean?Political chessboard: Will cannabis reform matte...
Higher Exchanges
This is a line-in-the-sand moment for legal cannabis. In this episode of Higher Exchanges, Jesse Redmond and Morgan Paxhia break down the Schedule III announcement alongside policy expert Hirsh Jain and capital markets veteran Scott Grossman. We unpack what just happened, why it matters, and what could come next for cannabis policy and markets. We cover: • A clear overview of the Schedule III news and first reactions • What changes on the policy side — including CBD and Medicare...
